+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

AI-enabled Medical Devices Market Size, Share & Trends Analysis Report by Component (Software, Hardware), Technology (Machine Learning, NLP), Therapeutic Area, End Use, and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 100 Pages
  • September 2025
  • Region: Global
  • Grand View Research
  • ID: 6176698
REQUEST CUSTOMIZATION
Description Jump to:
The global AI-enabled medical devices market size was estimated at USD 18.89 Billion in 2025 and is projected to reach USD 255.76 billion by 2033, growing at a CAGR of 38.5% from 2025 to 2033. Growing adoption of personalized and precision medicine, medical imaging and diagnostics advancements, and a supportive regulatory and reimbursement landscape contribute to market growth.

In addition, increasing healthcare digitalization and rising investments and industry collaborations are some other factors fueling market growth further. Personalized medicine drives the adoption of AI-enabled medical devices by enabling tailored healthcare based on individual genetics, environment, and lifestyle. By analyzing genomic data, imaging scans, and clinical records, AI systems deliver actionable insights for precision therapies. These technologies facilitate early disease detection, risk stratification, and treatment monitoring aligned with personalized medical protocols.

Furthermore, advanced predictive analytics empower clinicians to manage patient health, proactively improving clinical outcomes. For instance, in January 2025, Lunit received FDA 510(k) clearance for its Lunit SCOPE IO, an AI-powered tissue analysis software designed for immuno-oncology. The solution helps identify tumor-infiltrating lymphocytes (TILs) in cancer tissues, supporting precision immunotherapy decisions.

Moreover, the evolution of AI algorithms, including deep learning, natural language processing, and computer vision, propels AI medical device capabilities. Improved algorithm accuracy enhances diagnostic precision and reduces error rates. These technological improvements facilitate expanded applications, including AI-assisted imaging, predictive risk modeling, and automated patient monitoring. For instance, in June 2025, Clairity, Inc. became the first FDA-authorized AI platform for breast cancer prediction, receiving De Novo authorization for CLAIRITY BREAST. This innovative platform predicts a woman’s five-year risk of developing breast cancer using only routine screening mammograms.

Global AI-enabled Medical Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global AI-enabled medical devices market report based on component, technology, therapeutic area, end use, and region:

Component Outlook (Revenue, USD Million, 2021-2033)

  • Software
  • Hardware
  • Services

Technology Outlook (Revenue, USD Million, 2021-2033)

  • Machine Learning
  • Natural Language Processing (NLP)
  • Computer Vision
  • Context-Aware Computing

Therapeutic Area Outlook (Revenue, USD Million, 2021-2033)

  • Cardiology
  • Neurology
  • Radiology
  • Oncology
  • Mental and Behavioral Health
  • Ophthalmology
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals & Clinics
  • Diagnostic Centers
  • Ambulatory Surgical Centers (ASCs)
  • Home Care Settings
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • MEA

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Component Segment
1.2.2. Technology Segment
1.2.3. Therapeutic Area Segment
1.2.4. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. AI-Enabled Medical Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising demand for early disease diagnosis and predictive healthcare
3.2.1.2. Increasing adoption of personalized medicine and precision healthcare approaches.
3.2.1.3. Growing use of wearables and remote patient monitoring devices.
3.2.1.4. Advancements in machine learning, deep learning, and big data analytics enabling smarter devices.
3.2.2. Market restraint analysis
3.2.2.1. Data security and privacy concerns
3.2.2.2. High costs of advanced devices
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. AI-Enabled Medical Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal Landscape
3.3.2.6. Social Landscape
Chapter 4. AI-Enabled Medical Devices Market: Component Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global AI-Enabled Medical Devices Market Component Movement Analysis
4.3. Global AI-Enabled Medical Devices Market Size & Trend Analysis, by Component, 2021-2033 (USD Million)
4.4. Software
4.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.5. Hardware
4.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.5.2. AI-enabled Medical Devices
4.5.2.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.5.3. Smart Wearables
4.5.3.1. Market estimates and forecasts, 2021-2033 (USD Million)
4.6. Services
4.6.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. AI-Enabled Medical Devices Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global AI-Enabled Medical Devices Market Technology Movement Analysis
5.3. Global AI-Enabled Medical Devices Market Size & Trend Analysis, by Technology, 2021-2033 (USD Million)
5.4. Machine Learning Algorithms
5.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.4.2. Deep learning
5.4.2.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.4.3. Supervised
5.4.3.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.4.4. Unsupervised
5.4.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.4.5. Others
5.4.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.5. Natural Language Processing (NLP)
5.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.6. Computer Vision Techniques
5.6.1. Market estimates and forecasts, 2021-2033 (USD Million)
5.7. Context-Aware Computing
5.7.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 6. AI-Enabled Medical Devices Market: Therapeutic Area Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global AI-enabled Medical Devices Market Therapeutic Area Movement Analysis
6.3. Global AI-enabled Medical Devices Market Size & Trend Analysis, by Therapeutic Area, 2021-2033 (USD Million)
6.4. Cardiology
6.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.5. Neurology
6.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.6. Radiology
6.6.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.7. Oncology
6.7.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.8. Mental and Behavioral Health
6.8.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.9. Ophthalmology
6.9.1. Market estimates and forecasts, 2021-2033 (USD Million)
6.10. Others
6.10.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 7. AI-Enabled Medical Devices Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global AI-Enabled Medical Devices Market End Use Movement Analysis
7.3. Global AI-Enabled Medical Devices Market Size & Trend Analysis, by End Use, 2021-2033 (USD Million)
7.4. Hospitals & Clinics
7.4.1. Market estimates and forecasts, 2021-2033 (USD Million)
7.5. Diagnostic Centers
7.5.1. Market estimates and forecasts, 2021-2033 (USD Million)
7.6. Ambulatory Surgical Centers (ASCs)
7.6.1. Market estimates and forecasts, 2021-2033 (USD Million)
7.7. Home Care Settings
7.7.1. Market estimates and forecasts, 2021-2033 (USD Million)
7.8. Others
7.8.1. Market estimates and forecasts, 2021-2033 (USD Million)
Chapter 8. AI-Enabled Medical Devices Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021-2033:
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework
8.4.1.3. Competitive scenario
8.4.1.4. U.S. Market estimates and forecasts, 2021-2033 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Competitive scenario
8.4.2.4. Canada market estimates and forecasts, 2021-2033 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Competitive scenario
8.4.3.4. Mexico market estimates and forecasts, 2021-2033 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework
8.5.1.3. Competitive scenario
8.5.1.4. UK market estimates and forecasts, 2021-2033 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. Germany market estimates and forecasts, 2021-2033 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. France market estimates and forecasts, 2021-2033 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. Italy market estimates and forecasts, 2021-2033 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Competitive scenario
8.5.5.4. Spain market estimates and forecasts, 2021-2033 (USD Million)
8.5.6. Norway
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Competitive scenario
8.5.6.4. Norway market estimates and forecasts, 2021-2033 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Competitive scenario
8.5.7.4. Sweden market estimates and forecasts, 2021-2033 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework
8.5.8.3. Competitive scenario
8.5.8.4. Denmark market estimates and forecasts, 2021-2033 (USD Million)
8.6. Asia-Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework
8.6.1.3. Competitive scenario
8.6.1.4. Japan market estimates and forecasts, 2021-2033 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. China market estimates and forecasts, 2021-2033 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. India market estimates and forecasts, 2021-2033 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. Australia market estimates and forecasts, 2021-2033 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. South Korea market estimates and forecasts, 2021-2033 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Thailand market estimates and forecasts, 2021-2033 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework
8.7.1.3. Competitive scenario
8.7.1.4. Brazil market estimates and forecasts, 2021-2033 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Argentina market estimates and forecasts, 2021-2033 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework
8.8.1.3. Competitive scenario
8.8.1.4. South Africa market estimates and forecasts, 2021-2033 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. UAE market estimates and forecasts, 2021-2033 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. Kuwait market estimates and forecasts, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Siemens Healthineers
9.4.1.1. Company overview
9.4.1.2. Financial Performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. GE Healthcare
9.4.2.1. Company overview
9.4.2.2. Financial Performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Philips Healthcare
9.4.3.1. Company overview
9.4.3.2. Financial Performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Medtronic
9.4.4.1. Company overview
9.4.4.2. Financial Performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Johnson & Johnson (Ethicon)
9.4.5.1. Company overview
9.4.5.2. Financial Performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Stryker
9.4.6.1. Company overview
9.4.6.2. Financial Performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Canon Medical Systems
9.4.7.1. Company overview
9.4.7.2. Financial Performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Zimmer Biomet
9.4.8.1. Company overview
9.4.8.2. Financial Performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Abbott Laboratories
9.4.9.1. Company overview
9.4.9.2. Financial Performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Boston Scientific
9.4.10.1. Company overview
9.4.10.2. Financial Performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. Exo Imaging, Inc.
9.4.11.1. Company overview
9.4.11.2. Financial Performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. Empatica
9.4.12.1. Company overview
9.4.12.2. Financial Performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives
9.4.13. Aidoc
9.4.13.1. Company overview
9.4.13.2. Financial Performance
9.4.13.3. Product benchmarking
9.4.13.4. Strategic initiatives
9.4.14. Clew Medical
9.4.14.1. Company overview
9.4.14.2. Financial Performance
9.4.14.3. Product benchmarking
9.4.14.4. Strategic initiatives
9.4.15. Eko Health
9.4.15.1. Company overview
9.4.15.2. Financial Performance
9.4.15.3. Product benchmarking
9.4.15.4. Strategic initiatives
9.4.16. Paige AI, Inc.
9.4.16.1. Company overview
9.4.16.2. Financial Performance
9.4.16.3. Product benchmarking
9.4.16.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global AI-enabled medical devices market, by region, 2021-2033 (USD Million)
Table 3 Global AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 4 Global AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 5 Global AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 6 Global AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 7 North America AI-enabled medical devices market, by country, 2021-2033 (USD Million)
Table 8 North America AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 9 North America AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 10 North America AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 11 North America AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 12 U.S. AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 13 U.S. AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 14 U.S. AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 15 U.S. AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 16 Canada AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 17 Canada AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 18 Canada AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 19 Canada AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 20 Mexico AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 21 Mexico AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 22 Mexico AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 23 Mexico AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 24 Europe AI-enabled medical devices market, by country, 2021-2033 (USD Million)
Table 25 Europe AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 26 Europe AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 27 Europe AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 28 Europe AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 29 UK AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 30 UK AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 31 UK AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 32 UK AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 33 Germany AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 34 Germany AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 35 Germany AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 36 Germany AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 37 France AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 38 France AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 39 France AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 40 France AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 41 Italy AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 42 Italy AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 43 Italy AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 44 Italy AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 45 Spain AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 46 Spain AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 47 Spain AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 48 Spain AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 49 Denmark AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 50 Denmark AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 51 Denmark AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 52 Denmark AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 53 Sweden AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 54 Sweden AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 55 Sweden AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 56 Sweden AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 57 Norway AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 58 Norway AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 59 Norway AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 60 Norway AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 61 Asia-Pacific AI-enabled medical devices market, by country, 2021-2033 (USD Million)
Table 62 Asia-Pacific AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 63 Asia-Pacific AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 64 Asia-Pacific AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 65 Asia-Pacific AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 66 China AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 67 China AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 68 China AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 69 China AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 70 Japan AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 71 Japan AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 72 Japan AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 73 Japan AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 74 India AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 75 India AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 76 India AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 77 India AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 78 South Korea AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 79 South Korea AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 80 South Korea AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 81 South Korea AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 82 Australia AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 83 Australia AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 84 Australia AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 85 Australia AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 86 Thailand AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 87 Thailand AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 88 Thailand AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 89 Thailand AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 90 Latin America AI-enabled medical devices market, by country, 2021-2033 (USD Million)
Table 91 Latin America AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 92 Latin America AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 93 Latin America AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 94 Latin America AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 95 Brazil AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 96 Brazil AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 97 Brazil AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 98 Brazil AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 99 Argentina AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 100 Argentina AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 101 Argentina AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 102 Argentina AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 103 MEA AI-enabled medical devices market, by country, 2021-2033 (USD Million)
Table 104 MEA AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 105 MEA AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 106 MEA AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 107 MEA AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 108 South Africa AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 109 South Africa AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 110 South Africa AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 111 South Africa AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 112 Saudi Arabia AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 113 Saudi Arabia AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 114 Saudi Arabia AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 115 Saudi Arabia AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 116 UAE AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 117 UAE AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 118 UAE AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 119 UAE AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
Table 120 Kuwait AI-enabled medical devices market, by component, 2021-2033 (USD Million)
Table 121 Kuwait AI-enabled medical devices market, by therapeutic area, 2021-2033 (USD Million)
Table 122 Kuwait AI-enabled medical devices market, by technology, 2021-2033 (USD Million)
Table 123 Kuwait AI-enabled medical devices market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Market formulation & validation
Figure 5 AI-enabled medical devices market: Market outlook
Figure 6 AI-enabled medical devices market: Segment outlook
Figure 7 AI-enabled medical devices market: Competitive landscape outlook
Figure 8 Parent market outlook
Figure 9 AI-enabled medical devices market driver impact
Figure 10 AI-enabled medical devices market restraint impact
Figure 11 AI-enabled medical devices market: Component outlook and key takeaways
Figure 12 AI-enabled medical devices market: Component movement analysis
Figure 13 Software market estimates and forecasts, 2021-2033 (USD Million)
Figure 14 Hardware market estimates and forecasts, 2021-2033 (USD Million)
Figure 15 Services market estimates and forecasts, 2021-2033 (USD Million)
Figure 16 Services market estimates and forecasts, 2021-2033 (USD Million)
Figure 17 AI-enabled medical devices market: Technology outlook and key takeaways
Figure 18 AI-enabled medical devices market: Technology movement analysis
Figure 19 Machine learning algorithms market estimates and forecasts, 2021-2033 (USD Million)
Figure 20 Deep learning market estimates and forecasts, 2021-2033 (USD Million)
Figure 21 Supervised market estimates and forecasts, 2021-2033 (USD Million)
Figure 22 Unsupervised market estimates and forecasts, 2021-2033 (USD Million)
Figure 23 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 24 Natural language processing (NLP) market estimates and forecasts, 2021-2033 (USD Million)
Figure 25 Computer vision market estimates and forecasts, 2021-2033 (USD Million)
Figure 26 Context-aware computing market estimates and forecasts, 2021-2033 (USD Million)
Figure 27 AI-enabled medical devices market: Therapeutic area outlook and key takeaways
Figure 28 AI-enabled medical devices market: Therapeutic area movement analysis
Figure 29 Cardiology market estimates and forecasts, 2021-2033 (USD Million)
Figure 30 Neurology market estimates and forecasts, 2021-2033 (USD Million)
Figure 31 Radiology market estimates and forecasts, 2021-2033 (USD Million)
Figure 32 Oncology market estimates and forecasts, 2021-2033 (USD Million)
Figure 33 Mental and behavioral health market estimates and forecasts, 2021-2033 (USD Million)
Figure 34 Ophthalmology market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 36 AI-enabled medical devices market: End use outlook and key takeaways
Figure 37 AI-enabled medical devices market: End use movement analysis
Figure 38 Hospitals & clinics market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 Diagnostic centers market estimates and forecasts, 2021-2033 (USD Million)
Figure 40 Ambulatory surgical centers (ASCs) market estimates and forecasts, 2021-2033 (USD Million)
Figure 41 Home care settings market estimates and forecasts, 2021-2033 (USD Million)
Figure 42 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Global AI-enabled medical devices market: Regional outlook and key takeaways
Figure 44 Global AI-enabled medical devices market: Regional movement analysis
Figure 45 North America market estimates and forecasts, 2021-2033 (USD Million)
Figure 46 U.S. key country dynamics
Figure 47 U.S. market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Canada key country dynamics
Figure 49 Canada market estimates and forecasts, 2021-2033 (USD Million)
Figure 50 Mexico key country dynamics
Figure 51 Mexico market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 Europe market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 UK key country dynamics
Figure 54 UK market estimates and forecasts, 2021-2033 (USD Million)
Figure 55 Germany key country dynamics
Figure 56 Germany market estimates and forecasts, 2021-2033 (USD Million)
Figure 57 France key country dynamics
Figure 58 France market estimates and forecasts, 2021-2033 (USD Million)
Figure 59 Italy key country dynamics
Figure 60 Italy market estimates and forecasts, 2021-2033 (USD Million)
Figure 61 Spain key country dynamics
Figure 62 Spain market estimates and forecasts, 2021-2033 (USD Million)
Figure 63 Denmark key country dynamics
Figure 64 Denmark market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 Sweden key country dynamics
Figure 66 Sweden market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Norway key country dynamics
Figure 68 Norway market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 Asia-Pacific market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 Japan key country dynamics
Figure 71 Japan market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 China key country dynamics
Figure 73 China market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 India key country dynamics
Figure 75 India market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 Thailand key country dynamics
Figure 77 Thailand market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 South Korea key country dynamics
Figure 79 South Korea market estimates and forecasts, 2021-2033 (USD Million)
Figure 80 Australia key country dynamics
Figure 81 Australia market estimates and forecasts, 2021-2033 (USD Million)
Figure 82 Latin America market estimates and forecasts, 2021-2033 (USD Million)
Figure 83 Brazil key country dynamics
Figure 84 Brazil market estimates and forecasts, 2021-2033 (USD Million)
Figure 85 Argentina key country dynamics
Figure 86 Argentina market estimates and forecasts, 2021-2033 (USD Million)
Figure 87 Middle East and Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 88 South Africa key country dynamics
Figure 89 South Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 90 Saudi Arabia key country dynamics
Figure 91 Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
Figure 92 UAE key country dynamics
Figure 93 UAE market estimates and forecasts, 2021-2033 (USD Million)
Figure 94 Kuwait key country dynamics
Figure 95 Kuwait market estimates and forecasts, 2021-2033 (USD Million)

Companies Mentioned

The leading players profiled in this AI-enabled Medical Devices market report include:
  • iemens Healthineers
  • E Healthcare
  • hilips Healthcare
  • edtronic
  • ohnson & Johnson (Ethicon)
  • tryker
  • anon Medical Systems
  • immer Biomet
  • bbott Laboratories
  • oston Scientific
  • xo Imaging, Inc.
  • mpatica
  • idoc
  • lew Medical
  • ko Health
  • aige AI, Inc.

Table Information

Report AttributeDetails
No. of Pages100
PublishedSeptember 2025
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 18.89 Billion
Forecasted Market Value ( USD ) by 2033 $ 255.76 Billion
Compound Annual Growth Rate38.5%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Middle East Artificial Intelligence in Healthcare Market Size, Share and Trends Analysis Report by Component (Hardware, Services, Software Solutions), Application, End Use, Technology (ML, NLP), and Country with Growth Forecasts, 2025-2033 - Product Image

Middle East Artificial Intelligence in Healthcare Market Size, Share and Trends Analysis Report by Component (Hardware, Services, Software Solutions), Application, End Use, Technology (ML, NLP), and Country with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Middle East
From
Middle East Smart Medical Devices Market Size, Share & Trends Analysis Report by Product (Diagnostics & Monitoring Devices, Therapeutic Devices), Distribution Channel, End-use, and Country with Growth Forecasts, 2025-2033 - Product Image

Middle East Smart Medical Devices Market Size, Share & Trends Analysis Report by Product (Diagnostics & Monitoring Devices, Therapeutic Devices), Distribution Channel, End-use, and Country with Growth Forecasts, 2025-2033

  • Report
  • 100 Pages
  • Middle East
From
Conversational AI in Healthcare Market Size, Share & Trends Analysis Report by Component (Chatbots, Virtual Assistants), Technology (Speech Recognition & Generation), Application, End Use, and Region with Growth Forecasts, 2025-2033 - Product Image

Conversational AI in Healthcare Market Size, Share & Trends Analysis Report by Component (Chatbots, Virtual Assistants), Technology (Speech Recognition & Generation), Application, End Use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 100 Pages
  • Global
From
U.S. Artificial Intelligence In Healthcare Market Size, Share & Trends Analysis Report By Component (Software, Solution, Services), By Application (Robot Assisted Surgery, Clinical Trials), By Technology, By End Use, And Segment Forecasts, 2025 - 2033 - Product Image

U.S. Artificial Intelligence In Healthcare Market Size, Share & Trends Analysis Report By Component (Software, Solution, Services), By Application (Robot Assisted Surgery, Clinical Trials), By Technology, By End Use, And Segment Forecasts, 2025 - 2033

  • Report
  • 100 Pages
  • United States
From
North America Artificial Intelligence in Healthcare Market Size, Share, and Trends Analysis Report by Component (Software Solutions, Hardware, Services), Application, End-use, Technology, and Country with Growth Forecasts, 2025-2033 - Product Image

North America Artificial Intelligence in Healthcare Market Size, Share, and Trends Analysis Report by Component (Software Solutions, Hardware, Services), Application, End-use, Technology, and Country with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • North America
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.